Michelle Lynn Hall

Michelle Lynn Hall

Company: Lilly and Company

Job title: Associate Vice President


Nose-to-brain Delivery of Oligonucleotides 4:30 pm

Showcasing the delivery to the brain remains an incredibly challenging but holds immense promise for nucleic acids Evaluating the state-of-the-art for oligonucleotide therapies to the CNS is highly invasive direct delivery (e.g.., intrathecal injection directly into the cerebrospinal fluid) Describing work using formulations and a localization device to deliver oligonucleotides as in a minimally-invasive way…Read more

day: Focus Day

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.